B
Bastiaan E. de Galan
Researcher at Radboud University Nijmegen
Publications - 5
Citations - 2556
Bastiaan E. de Galan is an academic researcher from Radboud University Nijmegen. The author has contributed to research in topics: Type 2 diabetes & Diabetes mellitus. The author has an hindex of 4, co-authored 5 publications receiving 2356 citations. Previous affiliations of Bastiaan E. de Galan include University of Sydney.
Papers
More filters
Journal ArticleDOI
Severe Hypoglycemia and Risks of Vascular Events and Death
Sophia Zoungas,Sophia Zoungas,Anushka Patel,John Chalmers,Bastiaan E. de Galan,Bastiaan E. de Galan,Qiang Li,Laurent Billot,Mark Woodward,Mark Woodward,Toshiharu Ninomiya,Bruce Neal,Stephen MacMahon,Diederick E. Grobbee,Andre Pascal Kengne,Michel Marre,Simon Heller +16 more
TL;DR: Severe hypoglycemia was strongly associated with increased risks of a range of adverse clinical outcomes, including respiratory, digestive, and skin conditions, and no relationship was found between repeated episodes of severe hypglycemia and vascular outcomes or death.
Journal ArticleDOI
Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in Diabetes
Toshiharu Ninomiya,Vlado Perkovic,Bastiaan E. de Galan,Bastiaan E. de Galan,Sophia Zoungas,Avinesh Pillai,Meg Jardine,Anushka Patel,Alan Cass,Bruce Neal,Neil R Poulter,Carl-Eric Mogensen,Mark E. Cooper,Michel Marre,Bryan Williams,Pavel Hamet,Giuseppe Mancia,Mark Woodward,Mark Woodward,Stephen MacMahon,John Chalmers +20 more
TL;DR: In this article, the effects of albuminuria and reduced estimated GFR (eGFR) on the risk for cardiovascular and renal events among individuals with type 2 diabetes were investigated. But, there was no evidence of an interaction between the effect of higher eGFR and lower UACR.
Journal ArticleDOI
Combined Effects of Routine Blood Pressure Lowering and Intensive Glucose Control on Macrovascular and Microvascular Outcomes in Patients With Type 2 Diabetes New results from the ADVANCE trial
Sophia Zoungas,Sophia Zoungas,Bastiaan E. de Galan,Bastiaan E. de Galan,Toshiharu Ninomiya,Diederick E. Grobbee,Pavel Hamet,Simon Heller,Stephen MacMahon,Michel Marre,Bruce Neal,Anushka Patel,Mark Woodward,Mark Woodward,John Chalmers +14 more
TL;DR: The effects of routine blood pressure lowering and intensive glucose control were independent of one another, and when combined, they produced additional reductions in clinically relevant outcomes.
Journal ArticleDOI
Lowering Blood Pressure Reduces Renal Events in Type 2 Diabetes
Bastiaan E. de Galan,Bastiaan E. de Galan,Vlado Perkovic,Toshiharu Ninomiya,Avinesh Pillai,Anushka Patel,Alan Cass,Bruce Neal,Neil R Poulter,Stephen B. Harrap,Carl Erik Mogensen,Mark E. Cooper,Michel Marre,Bryan Williams,Pavel Hamet,Giuseppe Mancia,Mark Woodward,Paul Glasziou,Diederick E. Grobbee,Stephen MacMahon,John Chalmers +20 more
TL;DR: BP-lowering treatment with perindopril-indapamide administered routinely to individuals with type 2 diabetes provides important renoprotection, even among those with initial BP <120/70 mmHg, and a BP threshold below which renal benefit is lost is not identified.
Effects of intensive blood glucose control on vascular outcomes in patients with type 2 diabetes
Laurent Billot,Severine Bompoint,John Chalmers,Bastiaan E. de Galan,Rohina Joshi,Stephen MacMahon,B Neal,Anushka Patel,Mark Woodward,Mark E. Cooper,Paul Glasziou,Diederick E. Grobbee,Pavel Hamet,Stephen B. Harrap,Simon Heller,Lisheng Liu,Giuseppe Mancia,Michel Marre,Carl-Erik Mogensen,C. Y. Pan,Neil Poulter,Anthony Rodgers,F. Travert,B. Williams +23 more